Analyse produit facultative
Avec votre autorisation, nous utilisons une analyse limitée et respectueuse de la vie privée pour comprendre les parcours de recherche utiles. Nous n’utilisons ni traceurs publicitaires ni enregistrement de session. Vous pouvez modifier ce choix dans les préférences. Consultez la Politique de confidentialité.
Raymond James Financial Inc.'s published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $30.4B | |
|---|---|---|
| Revenue (ttm) | 15.2B | |
| Net income (ttm) | 2.3B | |
| EPS (ttm) | $11.5 | |
| Shares out | 192.4M | |
| P/E (trailing) | 13.7x | |
| P/E (forward) | 11.3x | |
| Dividend | $2.16 (1.37%) | |
| Volume | 1,501,961 | |
| Beta | 0.95 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | Trend |
| Revenue | $11.31B | $12.99B | $14.92B | $15.91B | — | +12.1% |
| Gross profit | $10.75B | $11.20B | $12.59B | $14.03B | — | +9.3% |
| Operating income | $2.02B | $7.21B | $2.64B | $4.56B | — | +31.1% |
| Net income | $1.51B | $1.74B | $2.07B | $2.14B | — | +12.3% |
| EPS (diluted) | $6.98 | $7.97 | $9.70 | $10.30 | $8.72 | +5.7% |
| EBITDA | $2.17B | $7.38B | $2.82B | $4.76B | — | +30.0% |
| R&D | $0 | $0 | — | — | — | +0.0% |
| SG&A | $7.33B | $7.30B | $8.21B | $7.24B | — | -0.4% |
Recent company headlines from major financial publishers.
The base case reflects steady organic asset gathering across Private Client Group affiliation channels, supported by disciplined non-compensation cost containment. At $158.21, the shares trade at an attractive discount to Fair value of $189.51, offering an implied upside of 19.8%. Under this path, the target reaches $189.51 with a probability of 60.0%, representing an expected return of 19.8%. Disconfirmation would occur if organic asset recruitment decelerates materially over consecutive reporting cycles.
The upside case envisions accelerating adviser recruiting across employee and independent channels, driving organic asset growth into the high single digits. A concurrent rebound in M&A advisory pipelines unfreezes capital markets activity, expanding operating margins toward top peer levels. Under this path, the target reaches $258.24 with a probability of 20.0%, representing an implied return of 63.2% toward Potential value of $258.24. Disconfirmation would emerge if transaction backlogs fail to convert as buyer-seller valuation spreads adjust.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 7.7% | $205 | $210 | $215 | $221 | $227 |
| 8.2% | $193 | $197 | $201 | $206 | $211 |
| 8.7% | $183 | $186 | $190 | $193 | $197 |
| 9.2% | $173 | $176 | $179 | $182 | $186 |
| 9.7% | $165 | $168 | $170 | $173 | $176 |
Upcoming earnings date and setup when available.
La notation portée par l'édition de recherche publiée chaque mois. Une notation compare le cours à la date d'analyse à la juste valeur ; elle n'indique pas si l'appréciation s'est révélée juste.
| Année | janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
